Trellus Health plc (AIM:TRLS)
London
· Delayed Price · Currency is GBP · Price in GBX 0.9500
-0.0490 (-5.16%)
Jun 6, 2025, 4:35 PM GMT+1
Trellus Health Revenue
In the year 2024, Trellus Health had annual revenue of $114.00K USD with 500.00% growth. Trellus Health had revenue of $50.00K in the half year ending June 30, 2024, with 400.00% growth.
Revenue
$114.00K
Revenue Growth
+500.00%
P/S Ratio
16.85
Revenue / Employee
$6.00K
Employees
19
Market Cap
1.53M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 114.00K | 95.00K | 500.00% |
| Dec 31, 2023 | 19.00K | 1,000.00 | 5.56% |
| Dec 31, 2022 | 18.00K | -7.00K | -28.00% |
| Dec 31, 2021 | 25.00K | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Trellus Health News
- 4 days ago - AIM Market Roundup: Celadon Pharma, Blue Star Capital, Synergia - The Armchair Trader
- 3 months ago - AIM Market Roundup: Trellus Health, Celadon Pharma, Nahl - The Armchair Trader
- 5 months ago - AIM Market Roundup: Trellus, Falcon Oil, MyHealthChecked - The Armchair Trader
- 5 months ago - AIM Market Roundup: Blue Star Capital, Trellus Health, Distil - The Armchair Trader